Proposed Merger Poses Operational and Valuation Risks for Select Medical

Select Medical (SEM) has disclosed a new risk, in the Corporate Activity and Growth category.

The announcement and pendency of the proposed Merger is likely to disrupt Select Medical’s operations, regardless of whether the transaction ultimately closes. Investor should consider risks such as employee attrition, diverted management attention and cash resources, strained stakeholder relationships, and limitations on strategic flexibility, all of which could pressure its results and valuation.

Overall, Wall Street has a Hold consensus rating on SEM stock based on 3 Holds.

To learn more about Select Medical’s risk factors, click here.